期刊文献+

临床实验室凝血四项检查正常参考范围的建立 被引量:5

The establishment of normal reference range of four tests for blood coagulation in clinical laborotary
暂未订购
导出
摘要 目的建立本实验室凝血四项正常参考值的范围。方法对本实验室2010年1月至2010年12月凝血四项日常检测数据进行统计分析。采用分段统计,结果优选的方法,各分段统计在反复剔除"±3s"后获得恒定均值(x)及标准差(s)并计算95%可信区间(x±1.96s),确定本室正常参考范围。结果本室凝血四项正常参考值为,凝血酶原时间(PT):10.7~14.7s,国际标准化比率(INR):0.78~1.17,活化部分凝血活酶时间(APTT):28.7~48.7s,纤维蛋白原(Fg):1.46~4.6g/L。结论建立了该实验室凝血四项正常参考值的范围,能满足临床要求。 Objective To establish normal reference range of four tests for blood coagulation in clinical laborotary. Methods The coagulation test data from January 2010 to December 2010 was collected for statistical analysis, statistics were did in different ranges ,optimal ranges were chosen. After repeated exclude "±3s" constant mean(g), standard deviation(s) and 95 % confidence in- tervals( ± 1.96s) were obtained in each statistical segment. Then the normal reference ranges were determined. Results The normal reference range of four tests for blood coagulation in the clinical lab:PT 10.7-14.7s,INR 0. 78-1.17,APTT 28. 7-48. 7 s,Fg 1.46-4.6 g/L. Conclusion Normal reference range of four tests for blood coagulation in clinical laborotary is established, which meets the clinical needs.
出处 《国际检验医学杂志》 CAS 2013年第15期1978-1979,共2页 International Journal of Laboratory Medicine
关键词 凝血酶原时间 激活部分促凝血酶原激酶时间 纤维蛋白原 参考范围 prothrombin time activated partial thromboplastin time fibrinogen reference ranges
  • 相关文献

参考文献7

二级参考文献30

  • 1常玉荣,石峻,郝东升,杨秋,苗丽娟.凝血四项检测正常参考值及其临床应用[J].华北煤炭医学院学报,2001,3(3):298-299. 被引量:4
  • 2白丽,孟艳秋,刘英淑.凝血实验的质量控制[J].实用医技杂志,2004,11(08B):1634-1635. 被引量:6
  • 3徐玉琳.我室凝血四项正常值的确定结果分析[J].大同医学专科学校学报,2005,25(1):27-27. 被引量:1
  • 4李云,李雪梅,王惠萱.凝血四项检测的影响因素[J].中国误诊学杂志,2006,6(11):2226-2227. 被引量:5
  • 5李涂生 陈宏础 等.临床检验基础[M].北京:人民卫生出版社,1995.62-65.
  • 6Fuentes-Arderiu X, Mas-Serra R, Aluma-Trullas A, et al. Guideline for the production of multicentre physiological reference values using the same measurement system. A proposal of the Catalan Association for Clinical Laboratory Sciences [ J ]. Clin Chem Lab Med, 2004,42 ( 7 ) : 778 - 782.
  • 7丛玉隆,今日临床检验学,1997年,191页
  • 8李涂生,临床检验基础,1995年,62页
  • 9Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end- stage liver disease. Hepatology, 2001,33: 464-470.
  • 10Ishikawa M, Yogita S, Miyake H, et al. Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma.Hepatogastroenterology, 2002, 49: 1625-1631.

共引文献115

同被引文献29

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部